\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\ \(157\)\
\-\ enhancing\\ preseptal\\ mass\\ at\\ the\\ superolateral\\ aspect\\ of\\ the\\ left\\ orbit\\ with\\ the\\ isocenter\\ within\\ the\\ lacrimal\\ gland\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ mass\\ within\\ the\\ superolateral\\ quadrant\\ of\\ the\\ orbit\ \(0\)\
\-\ lacrimal\\ tumor\\ \\(gland\\ or\\ duct\\)\ \(0\)\
\-\ dermoid\\ inclusion\\ cyst\ \(12\)\
\-\ metastases\ \(207\)\
\-\ sarcoidosis\ \(108\)\
\-\ pseudotmor\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ schwannoma\\ or\\ neurofibroma\ \(4\)\
\-\ left\\ eye\\ swelling\ \(3\)\
\-\ a\\ biopsy\\ revealed\\ non\\-hodgkin\\ b\\ cell\\ type\\ lymphoma\\.\\ \\ the\\ patient\\ had\\ no\\ history\\ of\\ systemic\\ lymphoma\\,\\ and\\ further\\ \\ evaluation\\ for\\ systemic\\ involvement\\ was\\ negative\\.\\ \\ as\\ such\\ local\\ radiation\\ is\\ the\\ treament\\ of\\ choice\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ superolateral\\:\\ 0\\.14532849633767622\ \(0\)\
\-\ lacrimal\\:\\ 0\\.1369361447155884\ \(0\)\
\-\ lymphoma\\:\\ 0\\.11492699455950521\ \(0\)\
\-\ isocenter\\:\\ 0\\.10371198145842939\ \(0\)\
\-\ pseudotmor\\:\\ 0\\.10371198145842939\ \(0\)\
\-\ orbit\\:\\ 0\\.10128609217528585\ \(0\)\
\-\ systemic\\:\\ 0\\.09619130835892135\ \(0\)\
\-\ treament\\:\\ 0\\.09555730874595944\ \(0\)\
\-\ gland\\:\\ 0\\.08563220450335692\ \(0\)\
\-\ preseptal\\:\\ 0\\.07786228054859151\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.0668238142122041\ \(0\)\
\-\ inclusion\\:\\ 0\\.06188435720561276\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.055740952706597395\ \(0\)\
\-\ choice\\:\\ 0\\.05201257963875364\ \(0\)\
\-\ b\\:\\ 0\\.047388549190405325\ \(0\)\
\-\ local\\:\\ 0\\.04617846230287935\ \(0\)\
\-\ duct\\:\\ 0\\.04609033675312455\ \(0\)\
\-\ schwannoma\\:\\ 0\\.04591604162624054\ \(0\)\
\-\ dermoid\\:\\ 0\\.04582985291927498\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.045408133721943966\ \(0\)\
\-\ metastases\\:\\ 0\\.042949793529917464\ \(0\)\
\-\ eye\\:\\ 0\\.04216952714249308\ \(0\)\
\-\ unknown\\:\\ 0\\.03923387647793537\ \(0\)\
\-\ within\\:\\ 0\\.03835603313849604\ \(0\)\
\-\ involvement\\:\\ 0\\.03684633713679784\ \(0\)\
\-\ biopsy\\:\\ 0\\.035666979313373655\ \(0\)\
\-\ quadrant\\:\\ 0\\.0353808933410124\ \(0\)\
\-\ type\\:\\ 0\\.0338896968040813\ \(0\)\
\-\ swelling\\:\\ 0\\.033491892517425084\ \(0\)\
\-\ radiation\\:\\ 0\\.032991191171321606\ \(0\)\
\-\ revealed\\:\\ 0\\.03226439870430698\ \(0\)\
\-\ further\\:\\ 0\\.03196993108000304\ \(0\)\
\-\ aspect\\:\\ 0\\.03157990511156891\ \(0\)\
\-\ enhancing\\:\\ 0\\.03152886509276187\ \(0\)\
\-\ such\\:\\ 0\\.03142744458636297\ \(0\)\
\-\ negative\\:\\ 0\\.03002494307499852\ \(0\)\
\-\ evaluation\\:\\ 0\\.029202809362668326\ \(0\)\
\-\ mass\\:\\ 0\\.027963788398766225\ \(0\)\
\-\ cell\\:\\ 0\\.027155773077429248\ \(0\)\
\-\ cyst\\:\\ 0\\.027016131012071794\ \(0\)\
\-\ or\\:\\ 0\\.023565241152087236\ \(0\)\
\-\ tumor\\:\\ 0\\.02343802707777425\ \(0\)\
\-\ left\\:\\ 0\\.022496594571127404\ \(0\)\
\-\ had\\:\\ 0\\.021692350814596566\ \(0\)\
\-\ as\\:\\ 0\\.015206794186989739\ \(0\)\
\-\ history\\:\\ 0\\.013884876914200981\ \(0\)\
\-\ at\\:\\ 0\\.0136207429744898\ \(0\)\
\-\ the\\:\\ 0\\.013011697383870664\ \(0\)\
\-\ was\\:\\ 0\\.011626794378984551\ \(0\)\
\-\ no\\:\\ 0\\.0101228723612212\ \(0\)\
\-\ patient\\:\\ 0\\.010077552128428093\ \(0\)\
\-\ for\\:\\ 0\\.008577742925208413\ \(0\)\
\-\ \\(\\:\\ 0\\.008498373249927771\ \(0\)\
\-\ \\)\\:\\ 0\\.008394561083685942\ \(0\)\
\-\ is\\:\\ 0\\.006615185628055595\ \(0\)\
\-\ of\\:\\ 0\\.005482531802258279\ \(0\)\
\-\ a\\:\\ 0\\.004665880021395309\ \(0\)\
\-\ \\,\\:\\ 0\\.003184824300203381\ \(0\)\
\-\ and\\:\\ 0\\.0021177530086143345\ \(0\)\
\-\ with\\:\\ 0\\.001376519718704585\ \(0\)\
\-\ \\.\\:\\ 0\\.001252924803435751\ \(0\)\
